Matthew Epplin

Matthew Epplin is a Senior Scientist at Arcus Biosciences, where Matthew has been employed since October 2020, following a role as Scientist. Prior experience includes a position as a Visiting PhD Student at The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on the design and synthesis of small molecule inhibitors for mood indications. Matthew Epplin holds a Doctor of Philosophy in Organic Chemistry from Emory University and completed a Postdoctoral Fellowship at Stanford University. Additionally, Matthew Epplin earned a Bachelor of Chemical Engineering from the University of Minnesota.